Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$268.26 - $339.48 $176,246 - $223,038
-657 Reduced 43.51%
853 $232,000
Q1 2024

May 14, 2024

SELL
$304.11 - $351.99 $431,836 - $499,825
-1,420 Reduced 48.46%
1,510 $522,000
Q4 2023

Feb 13, 2024

BUY
$269.37 - $365.04 $789,254 - $1.07 Million
2,930 New
2,930 $946,000
Q4 2019

Feb 12, 2020

BUY
$319.73 - $374.2 $658,643 - $770,852
2,060 New
2,060 $762,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Pearl River Capital, LLC Portfolio

Follow Pearl River Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pearl River Capital, LLC with notifications on news.